Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
New World Medical, Inc.
This is a prospective, nonrandomized, open-label study evaluating the safety and IOP-lowering effectiveness of CPI Visco-Surgical System (STREAMLINE™ SURGICAL SYSTEM) in patients with open-angle glaucoma undergoing cataract surgery.
Age
22–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects must meet all the following criteria in order to be eligible for participation in this study:
1. Subjects qualifying for cataract surgery
2. Subjects with diagnosis of open-angle glaucoma in at least one eye with unmedicated IOP of 21-36 mmHg.
You may not be if
Subjects are ineligible for participation in this study if s/he meets any of the following criteria:
1. Patients who could not be washed-out of IOP-lowering medications. .
Clareo Health | A FIH Trial of the STREAMLINE™ SURGICAL SYSTEM
